Integrating digital technologies to clinical research & trial operations.
JNPMEDI-Kangbuk Samsung Medical Center has signed an MOU on to collaborate in the “Patient-Centered Smart Clinical Trial Center.”
‘Decentralized clinical trial delivery in SaaS raises buyback rates’ / Youngyong Park, CTO
JNPMEDI Participates in the 2023 Drug Information Association.
JNPMEDI participated in the 2023 American Society of Clinical Oncology (ASCO) Korean Pavilion exhibition booth.
Launch of 'Maven Safety', a drug safety management solution
JNPMEDI distributes translated FDA guidelines for Decentralized Clinical Trials (DCT).